Your trusted source for investing success

Tag: 2019

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Azarga Uranium Executes Replacement Earn-in Agreement for Kyzyl Ompul Project

Azarga Uranium Executes Replacement Earn-in Agreement for Kyzyl Ompul Project

AZARGA URANIUM CORP. (TSX:AZZ) (“Azarga Uranium” or the “Company”) is pleased to announce that its 70% controlled subsidiary, UrAsia in Kyrgyzstan Limited Liability Company (“UrAsia”), has executed a replacement earn-in agreement (the “Agreement”) with Central Asian Uranium Company Limited Liability Corporation (“Central”), whose representatives were a party to the earn-in

Peeks Social Shareholders Approve Personas Transaction

Peeks Social (TSXV:PEEK), a company that deals with the development of social media and social commerce products and services for use by consumers and businesses with focus on mobile products announced that an annual and special meeting of shareholders was held on April 18.

The company said that the meeting was

Krystal Biotech’s KB103 Receives Orphan Medicinal Product Designation in Europe for Dystrophic Epidermolysis Bullosa

Krystal Biotech (NASDAQ:KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases, today announces that KB103, a gene therapy candidate for dystrophic epidermolysis bullosa (“DEB”), was granted Orphan Medicinal Product Designation (OMPD) from the European Medicines Agency (EMA).  KB103 represents the first

Hiku Brands and WeedMD to Merge in Transformational Transaction to Create Vertically Integrated Industry Leader

Hiku Brands and WeedMD to Merge in Transformational Transaction to Create Vertically Integrated Industry Leader

Hiku Brands Company Ltd. (“Hiku”) (CSE:HIKU) and WeedMD Inc. (TSXV:WMD, OTC:WDDMF) (FSE:4WE) (“WeedMD”), are pleased to announce that today they have entered into a definitive agreement (the “Arrangement Agreement”) to merge both companies, creating an industry leader (the “Transaction”). The Transaction combines two highly-complementary businesses and creates a unique and market differentiating vertically integrated company. Upon completion of

Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for Development of OPNT003

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced that it has been awarded a grant of approximately $7.4 million from the National Institutes of Health’s National Institute on Drug Abuse (NIDA) for the development of OPNT003 (intranasal nalmefene), a long-lasting opioid antagonist for the

Telson Mining Corporation Releases First Quarter 2018 Pre-Production Results from the Campo Morado Mine

Telson Mining Corporation Releases First Quarter 2018 Pre-Production Results from the Campo Morado Mine

Telson Mining Corporation (TSXV:TSN, OTCBB:SOHFF) (“Telson” or the “Company”) (Shares Issued: 125,726,075) is pleased to present pre-production results of development mining, concentrate production and metallurgical balances for the first three months of 2018 at its 100% owned Campo Morado Mine (“Campo Morado” or the “Project”) located in Guerrero State, Mexico.

Battery Metals in 2018


Click to download your free report


Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
5 Top Weekly NASDAQ Biotech Stocks: vTv Increases 163 Percent

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/5-top-weekly-nasdaq-biotech-stocks/